Sangamo Therapeutics (SGMO)
1.2300 +0.0150 (+1.23%) 09:22 ET [NASDAQ]
1.2300 x 3,900 1.2500 x 200
Realtime by (Cboe BZX)
1.2300 x 3,900 1.2500 x 200
Realtime 1.2500 +0.0350 (+2.88%) 09:14 ET
for Fri, Jan 10th, 2025
Results
download Want to compare other data? Select FieldsSymbol | SGMO | CMPX | ARTV | ||
Company | Sangamo Therapeutics | Compass Therapeutics Inc | Artiva Biotherapeutics Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 1.2300 | 1.9100 | 10.00 | ||
High | 1.2300 | 1.9100 | 11.55 | ||
Low | 1.2300 | 1.9100 | 10.00 | ||
Last | 1.2300 | 1.9250 | 10.23 | ||
Change | +0.0150 | +0.0650 | -0.03 | ||
% Change | +1.23% | +3.49% | -0.29% | ||
Volume | 128,137 | 449,040 | 62,300 | ||
20-Day Average Volume | 10,974,281 | 1,578,592 | 65,620 | ||
Previous Close | 1.2150 | 1.8600 | 10.58 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | Yes | No | No | ||
Technicals | |||||
20-Day Moving Average | 1.9765 | 1.5245 | 10.65 | ||
20-Day Raw Stochastic | 16.58% | 42.96% | 16.76% | ||
20-Day Relative Strength | 40.03% | 60.77% | 44.91% | ||
Weighted Alpha | -35.43 | +4.69 | N/A | ||
Today's Opinion | 24% Buy | 56% Buy | N/A | ||
Previous Opinion | 24% Buy | 48% Buy | N/A | ||
Last Month's Opinion | 88% Buy | 40% Buy | N/A | ||
Performance | |||||
5-Days | |||||
%Chg | +8.85% since 01/02/25 | +36.43% since 01/02/25 | +1.79% since 12/31/24 | ||
Low | 1.1200 on 01/03/25 | 1.4250 on 01/07/25 | 9.95 on 01/02/25 | ||
High | 1.5100 on 01/07/25 | 2.6800 on 01/08/25 | 11.55 on 01/08/25 | ||
1-Month | |||||
%Chg | -36.92% since 12/10/24 | +7.30% since 12/10/24 | -13.05% since 12/06/24 | ||
Low | 0.9100 on 12/31/24 | 1.3300 on 12/19/24 | 9.68 on 12/20/24 | ||
High | 2.8400 on 12/17/24 | 2.6800 on 01/08/25 | 13.14 on 12/11/24 | ||
3-Month | |||||
%Chg | +48.98% since 10/10/24 | +10.40% since 10/10/24 | -30.96% since 10/08/24 | ||
Low | 0.8100 on 10/11/24 | 1.2700 on 11/18/24 | 9.68 on 12/20/24 | ||
High | 3.1790 on 11/08/24 | 2.6800 on 01/08/25 | 16.87 on 10/11/24 | ||
6-Month | |||||
%Chg | +208.43% since 07/10/24 | +100.61% since 07/10/24 | N/A since 07/19/24 | ||
Low | 0.3723 on 07/19/24 | 0.8741 on 08/05/24 | 9.68 on 12/20/24 | ||
High | 3.1790 on 11/08/24 | 2.6800 on 01/08/25 | 17.31 on 10/01/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 253,506 | 255,916 | 249,205 | ||
Shares Outstanding, K | 208,647 | 137,589 | 24,289 | ||
Annual Sales | 176,230,000 | 0 | 33,492,000 | ||
Annual Net Income | -257,830,000 | -42,490,000 | -27,696,000 | ||
Last Quarter Sales | 49,410,000 | 850,000 | 0 | ||
Last Quarter Net Income | 10,670,000 | -13,080,000 | -17,840,000 | ||
60-Month Beta | 1.29 | 0.92 | N/A | ||
Per-Share Information | |||||
Most Recent Earnings | 0.04 on 11/12/24 | -0.08 on 11/12/24 | -0.92 on 11/12/24 | ||
Latest Earnings Date | 11/12/24 | 11/14/24 | 02/11/25 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |